AzTrials
AzTrials

Gender-based ViolenceNCT05331508

Testing Gender-based Violence Response in Family Planning and Antenatal Care Services in Nigeria

A study testing gender-based violence screening, first-line support (LIVES) and reproductive coercion empowerment counseling (ARCHES) in people with Gender-based Violence and Reproductive Coercion, run by Jhpiego at 40 sites in Nigeria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To pilot and evaluate the integration of first-line response to gender- based violence (GBV), particularly intimate partner violence (IPV), sexual violence and reproductive coercion, within family planning (FP) and antenatal care (ANC) services at public health facilities in Ebonyi and Sokoto states in Nigeria. Read more about this study

Who is it for?
Ages 18 to 49 years, women onlyHealthy volunteers can take part
What is being tested?
gender-based violence screening, first-line support (LIVES) and reproductive coercion empowerment counseling (ARCHES)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,756 participants
Where
40 sitesNigeria
Study dates
6 Apr 2022to 30 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 49 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Woman of reproductive age (18 to 49 years) seeking FP or ANC services at study sites
  • Women who believe they are able to conceive (i.e. who have not undergone a tubal ligation, hysterectomy, or oophorectomy, or are menopausal) (for FP clients)
  • Have a male partner they currently have sex with
  • Have a mobile phone that can be safely used for re-contacting for follow-up surveys
  • Do not have any accompanying male partners or family members aged 5 or above present

Who cannot join

  • Any individuals that do not meet all of the above inclusion criteria or do not agree to participate in the study will be excluded from data collection.
  • In addition, individuals with impaired cognitive abilities (I.e. unable to make decisions/respond to questions on their own without assistance by someone else)will also be excluded from the data collection.
  • Finally, women who share a mobile phone with their partner/husband or another family member will also be excluded.

Trial locations and contacts

40 sites in 1 country.

40 sites in 1 country

Nigeria40 sites
  • AZUIYIOKWU Health Center

    Abakaliki, Ebonyi State

  • GMELINA Health Center

    Abakaliki, Ebonyi State

  • NEW TIMBER SHADE Health Center

    Abakaliki, Ebonyi State

  • AMAECHARA Primary Health Center

    Afikpo North, Ebonyi State

  • Izeke Health Center

    Afikpo North, Ebonyi State

  • NKAGBOGO NDEMIYI MDG Primary Health Center

    Afikpo North, Ebonyi State

  • Owutu Primary Health Center

    Afikpo South, Ebonyi State

  • Uwana Primary Health Center

    Afikpo South, Ebonyi State

  • GH Bodinga

    Bodina, Sokoto State

  • Durbawa Primary Health Center

    Dange Sguni, Sokoto State

  • Kwannawa Primary Health Center

    Dange Sguni, Sokoto State

  • Ruga Dubu

    Dange Sguni, Sokoto State

  • MDG Randa

    Ebonyi, Ebonyi State

  • AZUNRAMURA Health Center

    Ezza, Ebonyi State

  • MCH Onueke

    Ezza South, Ebonyi State

  • GH Gada

    Gada, Sokoto State

  • Mamman Suka Primary Health Center

    Gwadabawa, Sokoto State

  • Cottage Hospital

    Ikwo, Ebonyi State

  • Echara Health Center

    Ikwo, Ebonyi State

  • Item Health Center

    Ikwo, Ebonyi State

  • Noyo Health Center

    Ikwo, Ebonyi State

  • Araba Health Center

    Ilela, Sokoto State

  • Darna Sabon Gari Health Center

    Ilela, Sokoto State

  • Garu

    Ilela, Sokoto State

  • Gidan Chiwake Health Center

    Ilela, Sokoto State

  • Gidan Hamma Health Center

    Ilela, Sokoto State

  • Kalmalo

    Ilela, Sokoto State

  • Rungumawar Gatti Health Center

    Ilela, Sokoto State

  • Tozai Health Center

    Ilela, Sokoto State

  • NDIOKOROUKWU Health Center

    Ivo, Ebonyi State

  • AKAEZEUKWU Health Center

    Ivo, Sokoto State

  • Durbawa Primary Health Center

    Kware, Sokoto State

  • Anike Health Center

    Onicha, Ebonyi State

  • Okaria Health Center

    Onicha, Ebonyi State

  • Oshiri Health Center

    Onicha, Ebonyi State

  • Gan Gam Primary Health Center

    Shagari, Sokoto State

  • Horo Primary Health Center

    Shagari, Sokoto State

  • Kajiji Primary Health Center

    Shagari, Sokoto State

  • Sanyinnawal Primary Health Center

    Shagari, Sokoto State

  • Kaura Kimba Health Post

    Wamako, Sokoto State

Other trials in Nigeria

About this study

Official title: Testing the Integration of Gender-based Violence First-line Response in Family Planning and Antenatal Care Services in Nigeria

To pilot and evaluate the integration of first-line response to gender- based violence (GBV), particularly intimate partner violence (IPV), sexual violence and reproductive coercion, within family planning (FP) and antenatal care (ANC) services at public health facilities in Ebonyi and Sokoto states in Nigeria.

GBV first-line response in the health setting includes screening , empowerment counseling, safety planning, and support to connect to additional services needed.

Read the detailed description

This study seeks to:

  1. Assess effectiveness of an integrated service delivery model (integration of GBV first-line response and empowerment counseling in standard of care FP or ANC services) in reducing on-going experience of intimate partner violence (IPV) and increasing utilization of modern contraceptive methods among clients.

1a. Assess effectiveness of the intervention in reducing IPV, increasing utilization of modern contraceptive methods, and improving safety and self-efficacy among clients seeking interval FP services.

1b. Assess effectiveness of the intervention in reducing IPV and improving safety and self-efficacy to seek GBV care among clients seeking ANC services.

  1. Explore factors influencing feasibility, acceptability and ability to implement GBV first-line response as part of FP and ANC services.
Being tested
gender-based violence screening, first-line support (LIVES) and reproductive coercion empowerment counseling (ARCHES)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • gender-based violence screening, first-line support (LIVES) and reproductive coercion empowerment counseling (ARCHES)Behavioural

    Also called GBV screening, LIVES and ARCHES

    Providers will (1) introduce routine client screening for GBV, including intimate partner violence, sexual violence, and reproductive coercion using a standardized screening form, in FP and ANC services,(2) for individuals disclosing GBV, provide first-line response-empathetic counseling, including listening, inquiring about experiences sensitively, and validating experiences, helping clients develop safety plans, and providing support; (3) regardless of disclosure of GBV, provide counseling and information, education and communication (IEC) materials on IPV, including reproductive coercion, and FP options, to both FP and ANC clients.

Study groups in NCT05331508
Study groupRoleWhat they receive
Treatment groupExperimentalPrior to commencement of the study, providers responsible for FP and ANC service provision will participate in a 3-day competency-based skills-building training activity on Caring for women subjected to violence: A WHO curriculum for training health-care providers and the ARCHES intervention. Following the training, providers will (1) introduce routine client screening for GBV, including intimate partner violence, sexual violence, and reproductive coercion using a standardized screening form, in FP and ANC services,(2) for individuals disclosing GBV, provide first-line response-empathetic counseling, including listening, inquiring about experiences sensitively, and validating experiences, helping clients develop safety plans, and providing support; (3) regardless of disclosure of GBV, provide counseling and information, education and communication (IEC) materials on IPV, including reproductive coercion, and FP options, to both FP and ANC clients.
Receives: Behavioral: gender-based violence screening, first-line support (LIVES) and reproductive coercion empowerment counseling (ARCHES)
Control groupNo interventionFP clients and ANC clients will receive standard care. For FP services, this includes standard contraceptive care provided by personnel who have completed training on contraceptive service delivery by the Nigerian Federal Ministry of Health and partners. For ANC services, the standard is a minimum of 8 visits with health personnel trained on ANC care during pregnancy. This includes identification of women and girls at increased risk of developing complications during labor and childbirth; prevention, detection, and management of pregnancy-related and concurrent conditions; health education and promotion; promotion of the use of skilled attendance at birth and healthy behaviors such as breastfeeding, early postnatal care, and planning for optimal pregnancy spacing, routine examinations, detection of complications, prevention of malaria in pregnancy and other infections; provision of holistic care to ensure normal progression of the baby and good health of the mother.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in percentage of clients disclosing exposure to intimate partner or sexual violence in past 3 months

    Disclosure will be defined by a positive response to either of the following questions:

    • Has your current partner ever slapped you, punched you, hit or kicked you, or done anything else to hurt you physically?
    • Has your current male partner ever forced you to have sex or do something sexual when you didn't want to?

    Measured: baseline to 3-months and 6-months post-intervention

  2. Percentage of clients that report receiving a family planning method from healthcare provider

    Measured: day of intervention

Secondary outcomes (4)
  1. Change in percentage of clients demonstrating family planning self efficacy, as measured by Contraceptive Self-Efficacy among women in sub-Saharan Africa (CSESSA) sub-scale

    Family planning self-efficacy is a women's belief about her own ability to complete the actions necessary for successful family planning.

    Measured: baseline to 3-months and 6-months post-intervention

  2. Change in demonstrated self-efficacy to access IPV services

    Self-efficacy to access IPV services is an IPV survivor's confidence to develop and execute a plan when her partner becomes violent/ if her partner were to become violent. Self-efficacy will be defined by an affirmative response to the following questions:

    • I am confident that I could develop a plan for seeking help 'when my partner becomes violent/ if my partner were to become violent'
    • I am confident that I would be able to execute my plan 'in times when my partner becomes violent / if my partner were to become violent'.

    Measured: baseline to 3-months and 6-months post-intervention

  3. Change in self-reported use of safety measures to protect respondent or her child/children from violence

    Whether an IPV survivor has ever done any of the following to protect herself or her child/children for fear that her partner would become violent:

    • Identified a safe place to go in case she needs to leave her home ?
    • Identified a friend or relative to whom she could seek help?
    • Set aside some things she may need, such as clothes, documents in case she needs to leave in a hurry?
    • Set aside funds in case she needs to leave your home/partner?
    • Made a plan for what she would do with her child/children in case she needs to leave home?

    Measured: baseline to 3-months and 6-months post-intervention

  4. Change in percentage of clients reporting experiences of reproductive coercion in 3 months prior to data collection

    Reproductive coercion is behavior that interferes with the autonomous decision-making of a woman, with regards to reproductive health, including whether client felt pressured or forced by current partner to become pregnant or made it difficult to use family planning. Reproductive coercion will be defined by a positive response to either of the following questions:

    • Have you ever felt pressured or forced by your current partner to become pregnant when you did not want to be?
    • Has your current partner ever made it difficult for you to get family planning or to use family planning?

    Measured: baseline to 3-months and 6-months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2022
  2. Study start6 Apr 2022
  3. Primary completion30 Apr 2023
  4. Study completion30 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,756 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05331508
Sponsor's protocol ID
MCGL-IRB17494
Status last verified
Aug 2023
First submitted
28 Feb 2022
Last updated
7 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Uysal J, Carter N, Johns N, Boyce S, Liambila W, Undie CC, Muketo E, Adhiambo J, Gray K, Wendoh S, Silverman JG. Protocol for a matched-pair cluster control trial of ARCHES (Addressing Reproductive Coercion in Health Settings) among women and girls seeking contraceptive services from community-based clinics in Nairobi, Kenya. Reprod Health. 2020 May 27;17(1):77. doi: 10.1186/s12978-020-00916-9.

    PubMed 32460786
  • Pallitto C, Garcia-Moreno C, Stoeckl H, Hatcher A, MacPhail C, Mokoatle K, Woollett N. Testing a counselling intervention in antenatal care for women experiencing partner violence: a study protocol for a randomized controlled trial in Johannesburg, South Africa. BMC Health Serv Res. 2016 Nov 5;16(1):630. doi: 10.1186/s12913-016-1872-x.

    PubMed 27814706
  • Bacchu L, Mezey G, Bewley S. Women's perceptions and experiences of routine enquiry for domestic violence in a maternity service. BJOG. 2002 Jan;109(1):9-16. doi: 10.1111/j.1471-0528.2002.00514.x.

    PubMed 11843378
  • Boyle A, Jones PB. The acceptability of routine inquiry about domestic violence towards women: a survey in three healthcare settings. Br J Gen Pract. 2006 Apr;56(525):258-61.

    PubMed 16611513
  • McDonnell E, Holohan M, Reilly MO, Warde L, Collins C, Geary M. Acceptability of routine enquiry regarding domestic violence in the antenatal clinic. Ir Med J. 2006 Apr;99(4):123-4.

    PubMed 16972587
  • Waalen J, Goodwin MM, Spitz AM, Petersen R, Saltzman LE. Screening for intimate partner violence by health care providers. Barriers and interventions. Am J Prev Med. 2000 Nov;19(4):230-7. doi: 10.1016/s0749-3797(00)00229-4.

    PubMed 11064226
  • Hamberger L.K.; Guse C.; Boerger J.; Minsky D.; Pape D.; Folsom C. Evaluation of a Health Care Provider Training Program to Identify and Help Partner Violence Victims. Journal of Family Violence, Volume 19, Number 1, February 2004, pp. 1-11

  • McNulty A, Andrews P, Bonner M. Can screening for domestic violence be introduced successfully in a sexual health clinic? Sex Health. 2006 Sep;3(3):179-82. doi: 10.1071/sh05056.

    PubMed 17044223
  • McNutt LA, Carlson BE, Rose IM, Robinson DA. Partner violence intervention in the busy primary care environment. Am J Prev Med. 2002 Feb;22(2):84-91. doi: 10.1016/s0749-3797(01)00407-x.

    PubMed 11818176
  • Taft A, Colombini M. Healthcare system responses to intimate partner violence in low and middle-income countries: evidence is growing and the challenges become clearer. BMC Med. 2017 Jul 12;15(1):127. doi: 10.1186/s12916-017-0886-5.

    PubMed 28697810
  • McFarlane JM, Groff JY, O'Brien JA, Watson K. Secondary prevention of intimate partner violence: a randomized controlled trial. Nurs Res. 2006 Jan-Feb;55(1):52-61. doi: 10.1097/00006199-200601000-00007.

    PubMed 16439929
  • Tiwari A, Leung WC, Leung TW, Humphreys J, Parker B, Ho PC. A randomised controlled trial of empowerment training for Chinese abused pregnant women in Hong Kong. BJOG. 2005 Sep;112(9):1249-56. doi: 10.1111/j.1471-0528.2005.00709.x.

    PubMed 16101604
  • Miller E, Decker MR, McCauley HL, Tancredi DJ, Levenson RR, Waldman J, Schoenwald P, Silverman JG. A family planning clinic partner violence intervention to reduce risk associated with reproductive coercion. Contraception. 2011 Mar;83(3):274-80. doi: 10.1016/j.contraception.2010.07.013.

    PubMed 21310291
  • Kiely M, El-Mohandes AAE, El-Khorazaty MN, Gantz MG. An integrated intervention to reduce intimate partner violence in pregnancy: a randomized controlled trial. Obstet Gynecol. 2010 Feb;115(2 Pt 1):273-283. doi: 10.1097/AOG.0b013e3181cbd482.

    PubMed 20093899
  • Betron M, Bryce E, Obafemi S, Yusuf S, Abdullahi H, Ifemenam E, Dikeocha N, Maiakwai A, Kabir B, Oduenyi C. Effectiveness of a clinic-based counselling intervention on risk of experiencing intimate partner violence and reproductive coercion: a matched-pair cluster-controlled trial in Ebonyi and Sokoto, Nigeria. BMJ Glob Health. 2025 Oct 28;10(10):e016898. doi: 10.1136/bmjgh-2024-016898.

    PubMed 41151831

Questions about this trial

What is this clinical trial studying?

A study testing gender-based violence screening, first-line support (LIVES) and reproductive coercion empowerment counseling (ARCHES) in people with Gender-based Violence and Reproductive Coercion, run by Jhpiego at 40 sites in Nigeria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 40 sites in Nigeria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in percentage of clients disclosing exposure to intimate partner or sexual violence in past 3 months (time frame: baseline to 3-months and 6-months post-intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05331508, which also lists 15 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in